Jan Chyi-Feng Jeff, Chang Che-Jui Jerry, Hwang Shinn-Jang, Chen Tzeng-Ji, Yang Hsiao-Yu, Chen Yu-Chun, Huang Cheng-Kuo, Chiu Tai-Yuan
Family Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Family Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
BMJ Open. 2021 Feb 16;11(2):e039986. doi: 10.1136/bmjopen-2020-039986.
The objective of this study was to explore the impact of Taiwan's Family Practice Integrated Care Project (FPICP) on hospitalisation.
A population-based cohort study compared the hospitalisation rates for ambulatory care sensitive conditions (ACSCs) among FPICP participating and non-participating patients during 2011-2015.
The study accessed the FPICP reimbursement database of Taiwan's National Health Insurance (NHI) administration containing all NHI administration-selected patients for FPICP enrolment.
The NHI administration-selected candidates from 2011 to 2015 became FPICP participants if their primary care physicians joined the project, otherwise they became non-participants.
The intervention of interest was enrolment in the FPICP or not. The follow-up time interval for calculating the rate of hospitalisation was the year in which the patient was selected for FPICP enrolment or not.
The study's primary outcome measures were hospitalisation rates for ACSC, including asthma/chronic obstructive pulmonary disease (COPD), diabetes or its complications and heart failure. Logistic regression was used to calculate the ORs concerning the influence of FPICP participation on the rate of hospitalisation for ACSC.
The enrolled population for data analysis was between 3.94 and 5.34 million from 2011 to 2015. Compared to non-participants, FPICP participants had lower hospitalisation for COPD/asthma (28.6‰-35.9‰ vs 37.9‰-42.3‰) and for diabetes or its complications (10.8‰-14.9‰ vs 12.7‰-18.1‰) but not for congestive heart failure. After adjusting for age, sex and level of comorbidities by logistic regression, participation in the FPICP was associated with lower hospitalisation for COPD/asthma (OR 0.91, 95% CI 0.87 to 0.94 in 2015) and for diabetes or its complications (OR 0.87, 95% CI 0.83 to 0.92 in 2015).
Participation in the FPICP is an independent protective factor for preventable ACSC hospitalisation. Team-based community healthcare programs such as the FPICP can strengthen primary healthcare capacity.
本研究旨在探讨台湾家庭医疗整合照护计划(FPICP)对住院治疗的影响。
一项基于人群的队列研究,比较了2011年至2015年期间参与和未参与FPICP的患者中门诊医疗敏感疾病(ACSCs)的住院率。
该研究访问了台湾国民健康保险(NHI)管理部门的FPICP报销数据库,其中包含所有NHI管理部门选定的参与FPICP的患者。
2011年至2015年期间,被NHI管理部门选定的候选人,如果其初级保健医生加入该项目,则成为FPICP参与者,否则成为非参与者。
感兴趣的干预措施是是否参与FPICP。计算住院率的随访时间间隔是患者被选定是否参与FPICP的年份。
该研究的主要结局指标是ACSC的住院率,包括哮喘/慢性阻塞性肺疾病(COPD)、糖尿病或其并发症以及心力衰竭。采用逻辑回归分析计算FPICP参与对ACSC住院率影响的比值比(OR)。
2011年至2015年期间,纳入数据分析的人群为394万至534万。与非参与者相比,FPICP参与者的COPD/哮喘住院率(28.6‰-35.9‰对37.9‰-42.3‰)和糖尿病或其并发症住院率(10.8‰-14.9‰对12.7‰-18.1‰)较低,但充血性心力衰竭住院率无差异。通过逻辑回归调整年龄、性别和合并症水平后,参与FPICP与较低的COPD/哮喘住院率(2015年OR 0.91,95%CI 0.87至0.94)和糖尿病或其并发症住院率(2015年OR 0.87,95%CI 0.83至0.92)相关。
参与FPICP是可预防的ACSC住院的独立保护因素。像FPICP这样的基于团队的社区医疗保健计划可以加强初级医疗保健能力。